Salesforce Stock Plunges 28% YTD: Should You Exit the Investment?

Salesforce (CRM) has significantly underperformed in 2025, with its stock down 28% year-to-date, contrasting sharply with the broader tech sector and competitors like SAP, Microsoft, and Oracle. This decline stems from decelerating growth, evidenced by Q1 fiscal 2026 revenue growth of just 7.7% and non-GAAP EPS growth of 5.7%, reflecting cautious enterprise spending and a shift towards smaller IT investments. While Salesforce's forward P/E of 20.08 appears low compared to peers and the sector, this valuation is deemed a 'value trap' given the company's diminished growth outlook and is accompanied by a Zacks Rank #4 (Sell) recommendation.

Analysis

Salesforce (CRM) is experiencing significant stock underperformance, with a 28% year-to-date decline that starkly contrasts with substantial gains from competitors SAP (+18.7%), Microsoft (+23.9%), and Oracle (+50.1%), and is more than double the 13.5% drop in the broader technology sector. This weakness is rooted in a fundamental deceleration of growth, as evidenced by first-quarter fiscal 2026 results where revenue and non-GAAP EPS grew by only 7.7% and 5.7%, respectively. This slowdown reflects a broader trend of cautious enterprise IT spending and a shift away from large-scale digital transformations. The company's future outlook appears muted, with analysts forecasting a continued mid-to-high single-digit growth profile and a projected five-year EPS CAGR of 12.9%, a sharp fall from the 27.8% achieved over the prior five years. While Salesforce trades at a forward P/E of 20.08, a notable discount to its peers and the sector average of 28.15, this is presented not as an opportunity but as a potential value trap, reflecting the market's pricing-in of a diminished growth story, a sentiment reinforced by its Zacks Rank #4 (Sell).

Key Decisions for Investors

• Investors should be cautious of the seemingly attractive valuation, as the low forward P/E of 20.08 likely reflects the market's consensus on a diminished growth outlook rather than a mispriced opportunity.
• Consider reallocating capital to peers like SAP, Microsoft, and Oracle, which have demonstrated superior stock performance and do not appear to be facing the same degree of growth deceleration.
• A bullish thesis on Salesforce should be deferred until management provides a clear strategic plan and tangible evidence of a return to double-digit revenue growth, as the current trajectory suggests limited upside.